HUP0101988A3 - Process for producing immunoglobulins for intravenous administration and other immunoglobulin products - Google Patents

Process for producing immunoglobulins for intravenous administration and other immunoglobulin products

Info

Publication number
HUP0101988A3
HUP0101988A3 HU0101988A HUP0101988A HUP0101988A3 HU P0101988 A3 HUP0101988 A3 HU P0101988A3 HU 0101988 A HU0101988 A HU 0101988A HU P0101988 A HUP0101988 A HU P0101988A HU P0101988 A3 HUP0101988 A3 HU P0101988A3
Authority
HU
Hungary
Prior art keywords
intravenous administration
immunoglobulin products
producing immunoglobulins
immunoglobulins
producing
Prior art date
Application number
HU0101988A
Other languages
English (en)
Original Assignee
Statens Seruminstitut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26150417&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0101988(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Statens Seruminstitut filed Critical Statens Seruminstitut
Publication of HUP0101988A2 publication Critical patent/HUP0101988A2/hu
Publication of HUP0101988A3 publication Critical patent/HUP0101988A3/hu
Publication of HU228076B1 publication Critical patent/HU228076B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
HU0101988A 1998-06-09 1999-06-09 Process for producing immunoglobulins for intravenous administration and other immunoglobulin products HU228076B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98201909 1998-06-09
US10205598P 1998-09-28 1998-09-28
PCT/DK1999/000312 WO1999064462A1 (en) 1998-06-09 1999-06-09 Process for producing immunoglobulins for intravenous administration and other immunoglobulin products

Publications (3)

Publication Number Publication Date
HUP0101988A2 HUP0101988A2 (hu) 2001-09-28
HUP0101988A3 true HUP0101988A3 (en) 2004-10-28
HU228076B1 HU228076B1 (en) 2012-10-29

Family

ID=26150417

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0101988A HU228076B1 (en) 1998-06-09 1999-06-09 Process for producing immunoglobulins for intravenous administration and other immunoglobulin products

Country Status (23)

Country Link
EP (4) EP1493751A1 (hu)
JP (1) JP5478519B2 (hu)
KR (1) KR100501263B1 (hu)
CN (1) CN1196714C (hu)
AT (1) ATE277950T1 (hu)
AU (1) AU753468B2 (hu)
BR (1) BR9911131A (hu)
CA (1) CA2330170C (hu)
CZ (1) CZ297199B6 (hu)
DE (1) DE69920693T2 (hu)
DK (1) DK1084147T3 (hu)
ES (1) ES2229784T3 (hu)
HK (2) HK1151044A1 (hu)
HU (1) HU228076B1 (hu)
ID (1) ID27417A (hu)
IL (1) IL140155A (hu)
NZ (1) NZ509135A (hu)
PL (1) PL196770B1 (hu)
PT (1) PT1084147E (hu)
RU (1) RU2197500C2 (hu)
SK (1) SK288128B6 (hu)
TR (1) TR200100303T2 (hu)
WO (1) WO1999064462A1 (hu)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2158776B1 (es) * 1999-04-13 2002-03-16 Apc Europ S A Procedimiento para la obtencion de gammaglobulinas de origen animal y aplicaciones correspondientes.
AUPQ026799A0 (en) * 1999-05-10 1999-06-03 Csl Limited Method of increasing protein stability by removing immunoglobulin aggregates
CA2400504A1 (en) * 2000-03-10 2001-09-13 Egil Lien Composition for the treatment of heart failure
SE0001128D0 (sv) * 2000-03-30 2000-03-30 Amersham Pharm Biotech Ab A method of producing IgG
ES2184594B1 (es) * 2001-01-17 2004-01-01 Probitas Pharma Sa Procedimiento para la produccion de gammaglobulina g humana inactivada de virus.
FR2824568B1 (fr) 2001-05-11 2004-04-09 Lab Francais Du Fractionnement Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique
US20030223985A1 (en) * 2002-05-29 2003-12-04 The Lauridsen Group. Incorporated Globulin protein to lower cholesterol in humans
ES2558303T3 (es) 2002-09-11 2016-02-03 Chugai Seiyaku Kabushiki Kaisha Método de purificación de proteínas
JPWO2004087761A1 (ja) * 2003-03-31 2006-07-27 麒麟麦酒株式会社 ヒトモノクローナル抗体およびヒトポリクローナル抗体の精製
EP1532983A1 (en) 2003-11-18 2005-05-25 ZLB Bioplasma AG Immunoglobulin preparations having increased stability
KR20070009995A (ko) * 2004-01-30 2007-01-19 수오멘 푸나이넨 리스티 베리팔베루 바이러스 안전성 면역글로불린을 제조하는 방법
ES2687671T3 (es) 2004-01-30 2018-10-26 Shire Pharmaceuticals Ireland Limited Arilsulfatasa A recombinante para reducir los niveles de galatosil sulfátidos en un sujeto
AU2005229674B2 (en) * 2004-11-18 2010-11-04 Kedrion Melville Inc. Low concentration solvent/detergent process of immuneglobulin with pre-treatment
TWI320788B (en) 2005-05-25 2010-02-21 Hoffmann La Roche Method for the purification of antibodies
KR101363777B1 (ko) 2005-09-30 2014-02-14 메디뮨 리미티드 인터루킨―１３ 항체 조성물
US9309316B2 (en) 2005-12-20 2016-04-12 Bristol-Myers Squibb Company Stable subcutaneous protein formulations and uses thereof
FR2895263B1 (fr) 2005-12-26 2008-05-30 Lab Francais Du Fractionnement Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives
CA2882501C (en) * 2006-04-04 2021-09-07 Zymenex A/S Compositions comprising alpha mannosidase and uses thereof
RU2303995C1 (ru) * 2006-04-28 2007-08-10 Халлар Абдумуслимович Алиханов Средство, обладающее иммунорегуляторным свойством и его применение для лечения аутоиммунных заболеваний
US8513393B2 (en) 2006-08-28 2013-08-20 Ares Trading S.A. Process for the purification of Fc-containing proteins
DE102007001521A1 (de) * 2007-01-10 2008-07-17 Matthias, Torsten, Dr. Verwendung von Cohn-Oncley-Fraktionen II und II/III zur Behandlung des systemischen Lupus erythematodes
RS53850B2 (sr) 2007-10-30 2018-07-31 Genentech Inc Pročišćavanje antitela hromatografijom izmene katjona
US8883146B2 (en) 2007-11-30 2014-11-11 Abbvie Inc. Protein formulations and methods of making same
US8772461B2 (en) 2008-04-15 2014-07-08 Grifols Therapeutics Inc. Two-stage ultrafiltration/diafiltration
FR2939667B1 (fr) 2008-12-17 2012-01-27 Fractionnement Et Des Biotechonologies Lab Franc Composition d'immunoglobine g comme medicament pour le traitement de l'ictere neonatal par incompatibilite foetomaternelle dans le systeme abo
TWI445714B (zh) 2009-05-27 2014-07-21 Baxter Int 產製用於皮下使用之高濃度免疫球蛋白製備物之方法
EP2519537A4 (en) * 2009-12-29 2013-07-10 Reddys Lab Ltd Dr CLEANING PROTEINS
AU2011212440B2 (en) 2010-02-04 2015-01-22 Csl Behring Ag Immunoglobulin preparation
EP2361636A1 (en) 2010-02-26 2011-08-31 CSL Behring AG Immunoglobulin preparation and storage system for an immunoglobulin preparation
GB201006753D0 (en) 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition
RU2467783C2 (ru) * 2010-07-30 2012-11-27 Закрытое акционерное общество "БиоХимМак СТ" Способ хроматографического выделения иммуноглобулина
EP3834851A1 (en) 2010-12-30 2021-06-16 Laboratoire Français du Fractionnement et des Biotechnologies Glycols as pathogen inactive agents
EP3318571B1 (en) 2011-03-16 2021-02-17 F. Hoffmann-La Roche AG Ion exchange chromatography with improved selectivity for the separation of polypeptide monomers, aggregates and fragments by modulation of the mobile phase
FR2974301B1 (fr) 2011-04-20 2013-08-23 Lab Francais Du Fractionnement Procede de preparation d'un produit plasmatique deplete en un ou plusieurs facteurs thrombogenes
IL212911A0 (en) * 2011-05-16 2011-07-31 Omrix Biopharmaceuticals Ltd Immunoglobulin reduced in thrombogenic contaminants and preparation thereof
EP2729566B1 (en) 2011-07-08 2017-03-15 Shire Human Genetic Therapies, Inc. Methods for purification of arylsulfatase a
JP6165143B2 (ja) * 2011-08-26 2017-07-19 バクスアルタ ゲーエムベーハー 血漿由来の免疫グロブリン組成物の血栓塞栓症の可能性を軽減する方法
CN102532307B (zh) * 2012-02-22 2013-06-12 成都蓉生药业有限责任公司 一种制备人免疫球蛋白的方法
PL2820042T3 (pl) 2012-02-29 2020-03-31 Baxalta GmbH Stymulowana przez igg remielinizacja nerwów obwodowych
SG11201404958SA (en) 2012-03-09 2014-11-27 Csl Behring Ag Compositions comprising secretory - like immunoglobulins
EP2636681A1 (en) 2012-03-09 2013-09-11 CSL Behring AG Process for enriching IgA
EP2636684A1 (en) 2012-03-09 2013-09-11 CSL Behring AG Prevention of infection
ES2381828B1 (es) * 2012-03-20 2012-11-16 Grifols, S.A. PROCEDIMIENTO PARA OBTENER UNA COMPOSICION DE IgG MEDIANTE TRATAMIENTO TERMICO
JP6297029B2 (ja) * 2012-05-31 2018-03-20 エイジェンシー・フォー・サイエンス，テクノロジー・アンド・リサーチ 多様な官能基を有する粒子による免疫グロブリンｇ調製物のクロマトグラフィー精製
JP6268167B2 (ja) 2012-05-31 2018-01-24 エイジェンシー フォー サイエンス，テクノロジー アンド リサーチ タンパク質製剤中の凝集物含量を低減するために混合型多官能表面を使用する方法
EP2682168A1 (en) 2012-07-02 2014-01-08 Millipore Corporation Purification of biological molecules
BR112015015948B1 (pt) 2013-01-09 2022-05-17 Takeda Pharmaceutical Company Limited Método de purificação da proteína arilsulfatase a (asa) recombinante
AU2013203043B2 (en) 2013-03-15 2016-10-06 Takeda Pharmaceutical Company Limited Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
WO2014186310A1 (en) 2013-05-13 2014-11-20 Momenta Pharmaceuticals, Inc. Methods for the treatment of neurodegeneration
CN105358571B (zh) 2013-07-01 2019-03-05 瑞士杰特贝林生物制品有限公司 方法
TW201509432A (zh) 2013-07-05 2015-03-16 Lab Francais Du Fractionnement 親和層析基質
US20160257754A1 (en) 2013-10-16 2016-09-08 Momenta Pharmaceuticals Inc. Sialylated glycoproteins
CN103665100A (zh) * 2014-01-03 2014-03-26 华兰生物工程重庆有限公司 低温乙醇提取静注人免疫球蛋白的方法
ES2785375T3 (es) 2014-03-11 2020-10-06 Green Cross Holdings Corp Procedimiento de purificación de inmunoglobulina
FR3018450B1 (fr) * 2014-03-11 2016-04-15 Lab Francais Du Fractionnement Procede de preparation de proteines plasmatiques humaines
EP3131589B1 (en) * 2014-04-15 2023-05-17 Boehringer Ingelheim International GmbH Method and use for continuously inactivating a virus during manufacture of a biological product
CN104004090A (zh) * 2014-06-12 2014-08-27 新疆德源生物工程有限公司 一种人免疫球蛋白的制备方法
CN104356231B (zh) * 2014-11-10 2017-08-08 北海开元生物科技有限公司 一种有效去除人免疫球蛋白多聚体的方法
US9556253B2 (en) 2014-12-02 2017-01-31 Hemarus Therapeutics Limited Process for increased yield of immunoglobulin from human plasma
FR3035971A1 (fr) 2015-05-07 2016-11-11 Lab Francais Du Fractionnement Composition enrichie en immunoglobulines polyclonales anti-a et/ou anti-b
KR101657690B1 (ko) 2015-06-05 2016-09-19 주식회사 녹십자홀딩스 혈장 유래 b형 간염 사람 면역글로불린 제제의 제조방법
CN105950576A (zh) * 2016-05-26 2016-09-21 成都远睿生物技术有限公司 一种从牛血中提取多种蛋白的方法
CN107880116B (zh) * 2016-09-30 2023-02-03 盖立复集团公司 用于制备免疫球蛋白的方法
FR3064484A1 (fr) 2017-03-31 2018-10-05 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Composition d'immunoglobulines utiles pour traiter des infections virales
FR3064485A1 (fr) 2017-03-31 2018-10-05 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Traitement d'une infection par le virus respiratoire syncytial
FR3064486A1 (fr) 2017-03-31 2018-10-05 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Prevention d'une infection par le virus respiratoire syncytial dans les voies respiratoires superieures
KR20190047376A (ko) 2017-10-27 2019-05-08 주식회사 녹십자 개선된 면역글로불린의 정제방법
CN109776675A (zh) * 2017-11-10 2019-05-21 北京博莱得利生物技术有限责任公司 两步离子交换层析法制备犬免疫球蛋白的方法
CN112574296B (zh) * 2020-12-30 2023-05-19 中国医学科学院输血研究所 一种模拟IVIg的多人份混合人血浆IgG样品的分离纯化方法
KR20230148961A (ko) * 2022-04-19 2023-10-26 에스케이플라즈마 주식회사 면역글로불린 정제방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2364792A1 (de) * 1973-01-15 1974-07-18 South African Inventions Verfahren zum reinigen von gammaglobulin
US4296027A (en) * 1977-08-31 1981-10-20 The Regents Of The University Of Minnesota Pure intravenous human and animal gamma globulins
US4315919A (en) 1980-10-06 1982-02-16 Edward Shanbrom Depyrogenation process
US4314997A (en) 1980-10-06 1982-02-09 Edward Shanbrom Purification of plasma protein products
US4764369A (en) 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
NZ216094A (en) * 1985-05-15 1989-06-28 Commw Serum Lab Commission Method for purification of an immunoglobulin
DE4118912C1 (hu) * 1991-06-08 1992-07-02 Biotest Pharma Gmbh, 6072 Dreieich, De
FR2706466B1 (fr) * 1993-06-14 1995-08-25 Aetsrn Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré.

Also Published As

Publication number Publication date
HK1151044A1 (en) 2012-01-20
EP1493751A1 (en) 2005-01-05
EP2272870B1 (en) 2013-05-08
JP5478519B2 (ja) 2014-04-23
ES2229784T3 (es) 2005-04-16
CN1311797A (zh) 2001-09-05
HUP0101988A2 (hu) 2001-09-28
BR9911131A (pt) 2001-03-06
EP2272870A1 (en) 2011-01-12
WO1999064462A1 (en) 1999-12-16
PT1084147E (pt) 2005-01-31
EP1084147B1 (en) 2004-09-29
KR100501263B1 (ko) 2005-07-18
HU228076B1 (en) 2012-10-29
CN1196714C (zh) 2005-04-13
CZ297199B6 (cs) 2006-09-13
CZ20004534A3 (en) 2001-06-13
DK1084147T3 (da) 2004-10-25
PL196770B1 (pl) 2008-01-31
CA2330170A1 (en) 1999-12-16
DE69920693D1 (de) 2004-11-04
SK18662000A3 (sk) 2001-07-10
RU2197500C2 (ru) 2003-01-27
RU2001101454A (ru) 2003-01-20
AU753468B2 (en) 2002-10-17
IL140155A0 (en) 2002-02-10
EP1084147A1 (en) 2001-03-21
EP2270044B1 (en) 2014-11-05
JP2011102314A (ja) 2011-05-26
EP2270044A1 (en) 2011-01-05
DE69920693T2 (de) 2005-11-03
IL140155A (en) 2005-12-18
ATE277950T1 (de) 2004-10-15
NZ509135A (en) 2002-10-25
ID27417A (id) 2001-04-05
KR20010052733A (ko) 2001-06-25
CA2330170C (en) 2010-11-02
TR200100303T2 (tr) 2001-06-21
PL344671A1 (en) 2001-11-19
AU4257299A (en) 1999-12-30
HK1151045A1 (en) 2012-01-20
SK288128B6 (sk) 2013-10-02

Similar Documents

Publication Publication Date Title
HUP0101988A3 (en) Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
EP0711658A3 (en) Molded multilayer articles and method of making them
ZA962248B (en) Nanususpensions for intravenous administration
GB2278604B (en) Altered antibodies,products and processes relating thereto
HUP9902841A3 (en) Catheter package and method for producing the same
HU9603484D0 (en) Pharmaceutical compositions and process for producing symptom-transduction
HUP9802340A3 (en) Process for producing oriented polymeric products
HUP9802839A3 (en) Quinazoline derivatives, pharmaceutical compositions containing them and process for producing them
HUP9801688A3 (en) Acetamide derivatives, process for producing the same, and medicinal composition containing the same
ZA969557B (en) Interferon polymer conjugates and process for preparing the same
HUP0000449A3 (en) N-subsituted dioxothiazolidylbenzamide derivatives and process for producing the same
HUP9603433A3 (en) 4-6-diaryl-pyrimidine-derivatives, process for producing them and pharmaceutical compositions containing them
EP0753395A4 (en) POLYESTER PRODUCT AND PROCESS FOR PRODUCING THE SAME
IL131471A0 (en) Production process for intravenous immune serum globulin and resultant product
HK1025223A1 (en) Bifidobacterium-fermented milk and process for producing the same
GB9422999D0 (en) Method and apparatus for the manufacture of infusion packages
GB9519539D0 (en) Polyester composition,polyester monofilament,process for producing the both and product made polyester monofilament
HU9501041D0 (en) Peptide-boronic acid derivatives, process for producing them and pharmaceutical application thereof
IL129383A0 (en) Method for producing an IgM preparation for intravenous administration
HU9503801D0 (en) Substituted 4-phenyl-thiazol derviatives, process for producing them and pharmaceutical compositions containing them
HUP9903902A3 (en) Bromotiacumicin compounds, process for producing them and medicaments containing the same
EP0702960A4 (en) LIQUID GLOBULIN COMPOSITION FOR INTRAVENOUS INJECTIONS, METHOD FOR THE PRODUCTION THEREOF, AND METHOD FOR PREVENTING THE INCREASE OF GLOBULIN DIMERES IN THE SAME
PL352910A1 (en) Manufacturing method for intravenous immune globulin and resultant product
HUP0003566A3 (en) Process for producing dosage form and the obtained product
HK101696A (en) Shirred pants and process for producing the same

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: CSL BEHRING AG, CH

Free format text: FORMER OWNER(S): STATENS SERUM INSTITUT, DK